Estimating long-term outcomes in classic Hodgkin lymphoma: a United States population-based oncology simulation model based on overall survival from the ECHELON-1 trial-Reference-Cited by-同舟云学术

Estimating long-term outcomes in classic Hodgkin lymphoma: a United States population-based oncology simulation model based on overall survival from the ECHELON-1 trial

Published:2023-04-16 Issue:5 Volume:64 Page:1017-1025
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Phillips Tycel¹,Migliaccio-Walle Kristen²,Yu Kristina S.³,Bloudek Brian²,Liu Nicholas³,Fanale Michelle³,Burke John M.⁴

Affiliation:

1. Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Medical School, Ann Arbor, MI, USA

2. Curta, Inc, Seattle, WA, USA

3. Seagen Inc, Bothell, WA, USA

4. US Oncology Hematology Research Program, Rocky Mountain Cancer Centers, Aurora, CO, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2023.2193854

Reference37 articles.

1. Pathobiology of Hodgkin Lymphoma

2. National Institutes of Health. Cancer stat facts: Hodgkin lymphoma 2022 [cited 2022 Aug 9]. Available from: https://seer.cancer.gov/statfacts/html/hodg.html

3. Hodgkin lymphoma: A review and update on recent progress

4. Cancer Statistics, 2021

5. CD30: an important new target in hematologic malignancies

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimated impact of ECHELON-1 overall survival on productivity costs in stage III/IV classical Hodgkin lymphoma in the United States;Journal of Managed Care & Specialty Pharmacy;2023-12

2. Brentuximab vedotin + AVD in cHL: cost impact on adverse events, toxicity, second malignancies, end-of-life and subsequent lines of therapy in Italy;AboutOpen;2023-10-02

3. Physician frontline treatment preferences for stage III/IV classic Hodgkin lymphoma: the real-world US CONNECT study;Future Oncology;2023-09-04